Next Article in Journal
Towards High-Throughput Chemobehavioural Phenomics in Neuropsychiatric Drug Discovery
Next Article in Special Issue
Cytotoxic and Antiproliferative Effects of Preussin, a Hydroxypyrrolidine Derivative from the Marine Sponge-Associated Fungus Aspergillus candidus KUFA 0062, in a Panel of Breast Cancer Cell Lines and Using 2D and 3D Cultures
Previous Article in Journal
Marine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular Evidence
Previous Article in Special Issue
In Vitro and In Silico Approaches to Generating and Identifying Angiotensin-Converting Enzyme I Inhibitory Peptides from Green Macroalga Ulva lactuca
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Bioactive Compounds Isolated from Marine-Derived Microbes in China: 2009–2018

School of Pharmaceutical Science and Technology, Health Science Platform, Tianjin University, 92 Weijin Road, Tianjin 300072, China
*
Author to whom correspondence should be addressed.
Mar. Drugs 2019, 17(6), 339; https://doi.org/10.3390/md17060339
Submission received: 10 May 2019 / Revised: 27 May 2019 / Accepted: 28 May 2019 / Published: 6 June 2019

Abstract

:
This review outlines the research that was carried out regarding the isolation of bioactive compounds from marine-derived bacteria and fungi by China-based research groups from 2009–2018, with 897 publications being surveyed. Endophytic organisms featured heavily, with endophytes from mangroves, marine invertebrates, and marine algae making up more than 60% of the microbial strains investigated. There was also a strong focus on fungi as a source of active compounds, with 80% of publications focusing on this area. The rapid increase in the number of publications in the field is perhaps most notable, which have increased more than sevenfold over the past decade, and suggests that China-based researchers will play a major role in marine microbial natural products drug discovery in years to come.

Graphical Abstract

1. Introduction

Natural products continue to be a major source of new compounds in the development of small-molecule drugs, whether that is directly, semi-synthetically, or as a source of inspiration or chemical scaffolds [1,2,3,4,5]. Recent reports state that drugs derived from natural products account for more than 40 billion USD in the market, not including the non-pharmaceutical uses of biologically active polyketides and terpenoids used in agriculture or aquaculture: where the markets are estimated to be worth 17 billion USD and 12 billion USD, respectively [6].
Microbial natural products are not only the most reported for their structural novelty, but they also have a wide array of biological properties with targets that are involved in numerous diseases, such as antibiotics, immunosuppressants, anti-diabetics, hormone (ion-channel or receptor) antagonists, anti-cancer drugs, and even as agricultural agents [7]. In spite of yielding great results, there are several challenges still remaining natural products research. One of the main challenges is the low percentage of microbes that can be readily cultured under laboratory conditions. It is estimated that one gram of fertile soil contains around 107 bacterial types, 105 actinomycetes spores, and 102 fungal spores [8], and we are only able to grow 5% of those microorganisms. Another challenge is the concentration of the desired metabolites in the laboratory cultures: microbial extracts are complex mixtures that can make the isolation and elucidation of microbial natural products a slow and tedious process. New techniques are being developed to address these issues, such as new methods for the isolation and culturing of bacteria, or the extraction and sequencing of metagenomics samples from soil or water samples [9], OSMAC strategies [10], genome mining [11], and metabolomic methods [12,13].
The help of these new technologies has granted us access to new microbiota, and it estimates that we are now able to analyze the genomes of at least 75% of the existing microbiota within a soil sample [8]. It is reported that, over the past three decades, 60% of the new anticancer agents and 75% of new antibiotics can be linked to NPs or their derivatives [8], and it seems clear that, despite the long history of research in the field, both microbes and the marine environment are still capable of yielding structurally novel compounds for the drug discovery process [14].
China offers an enormous potential resource of new microbial strains for chemical investigation. Chinese natural products have a long history, with medicinal traditions dating back thousands of years. Modern studies by Chinese researchers began in the 1930s, which focused on the chemistry of plants that are used in traditional medicinal preparations, and continue to be dominated by research into the natural products of plants [15]. The award of the 2015 Nobel Prize in Medicine to Tu Youyou for her discovery of the antimalarial agent artemisinin [16] illustrates the potential of Chinese natural products research to produce truly significant biologically active compounds.
However, it is only in the past few decades that China-based natural products researchers have turned from traditional sources of natural products discovery, such as plants, towards microbial and marine drug discovery research. In China, several groups are in the process of evaluating the potential of microbial natural products, for with its great land-mass, wide array of micro climates, and vast oceans, China may possess a unique microbial diversity and corresponding potential for novel chemistry [17,18,19]. High-profile research is being conducted into the pursuit of natural products that are isolated from marine bacterial sources [20,21,22], fungal endophytes from unusual sources, such as mangroves [23], in addition to a burgeoning crop of researchers in the field of natural products biosynthesis [24]. The oceans are one environment that has yielded particularly promising results: marine natural products have yielded diverse compounds over the past 20 years [25,26], many of which have shown potential as leads for drug development [27]. In the current review, we focus on the research of China-based research groups on the isolation of biologically active metabolites from marine-derived fungi and bacteria. Numerous examples of the bioactive molecules that were isolated from these sources over the past ten years are given. The origin of the strains, the diversity and biological properties of the compounds produced, and the numbers and venues for publication of this research are also summarized (Supplementary Table S1).

2. Polyketides

2.1. Bacterial Polyketides

Bacterial polyketides mainly consist of two major structural classes, according to their mode of biosynthesis: one group of polyketides is formed by modular polyketide synthases that produce polyketides tending to be linear structures or large macrolactone rings, with frequent alcohols, methyl branches, etc., while another group of polyketides, which are produced by iterative polyketide synthases, tend to have condensed aromatic structures [28]. Both classes are well represented in the literature from China (Figure 1 Figure 2 Figure 3). Most of the polyketides from the first structural class exerted significant antimicrobial activities, and they can be exemplified by the macrolactins isolated by Gao et al., including macrolactin V (1), a new 24-membered macrolide, along with macrolactin S (2), a known macrolide, from the marine bacterium Bacillus amyloliquefaciens SCSIO 00856. Antimicrobial testing showed that macrolactin V possessed potent antibacterial activity against E. coli, Bacillus subtilis, and Staphyloccous aureus, with an MIC value of 0.1 mg/ml [29].
As with terrestrial microbes, Streptomyces species isolated from marine microbes continue to be a rich source of new chemistry: examples include a group of 6-deoxyglycosidic elaiophylin derivatives, including two new antibiotics 11′,12′-dehydroelaiophylin (3) and 11,11′-O-dimethyl-14′-deethyl-14′-methylelaiophylin (4), which were obtained from the culture broth of a marine-derived Streptomyces sp. 7-145, along with four known analogues (58). It is worth noting that some of them displayed inhibitory activity against several methicillin-resistant S. aureus (MRSA) strains and vancomycin-resistant enterococci (VRE) pathogens, presenting MIC values of 1–2 μg/mL [30]. Chemical investigation of the culture broth of a deep-sea derived Streptomyces koyangensis SCSIO 5802 yielded three new polycyclic macrolactones, neoabyssomicins A–C (911), along with two known abyssomicins (12,13). They were assayed for antibacterial activity and the results showed that only the known abyssomicin 12 could inhibit the growth a panel of Gram-positive pathogens, with MIC values ranging from 3 to 15 μg/mL. However, it was found that neoabyssomicins A and C could inhibit the replication of the HIV-1 virus in MT-2 lymphocytes [31]. Subsequently, a further study on this strain by the same research group led to the discovery of another three new abyssomicin monomers, neoabyssomicins D (14), E (15), and A2 (16), together with two dimers neoabyssomicins F (17) and G (18). Amongst them, the two dimeric compounds displayed inhibitory activity against MRSA strains and vesicular stomatitis virus, respectively [32]. Three 16-membered macrolides, including two known compounds, named dihydrochalcomycin (19) and chalcomycin (20), in addition to one new compound chalcomycin E (21), were discovered from marine-derived Streptomyces sp. HK-2006-1. The antibacterial testing result showed that these two known compounds were active in inhibiting S. aureus, with MIC values of 32 µg/mL and 4 µg/mL, respectively [33]. Macrolide polyketides were not the only class isolated from Streptomyces isolates: another marine-derived Streptomyces sp. SCSGAA 0027 afforded four new polyhydroxylated polyketides, namely nahuoic acids B–E (2225), which contain a decalin ring. They displayed weak inhibitory activity against the biofilm formation of Shewanella onedensis MR-1 [34].
Other actinomycete genera have also been found to produce biologically active compounds. The fermentation broth of marine-derived actinomycete Micromonospora carbonacea LS276 provided a new spirotetronate, tetrocarcin Q (26), which possessed an unusual 2-deoxy-allose group. The spirotetronate family features an unusual macrolide that is composed of a characteristic tetronic acid, a trans-decalin system, together with two sugar side chains. Tetrocarcin Q showed moderate antibacterial activity against Bacillus subitlis ATCC 63501, with an MIC value of 12.5 µM [35].
Condensed aromatic polyketides are also well represented in the literature from Chinese researchers, possessing diverse biological activities, including antibacterial, antifungal, anticancer, and antioxidant properties. These include saccharothrixones A–D (2730), four new tetracenomycin-type aromatic polyketides, which were isolated from a marine-derived actinomycete Saccharothrix sp. 10-10. Among them, saccharothrixone D showed moderate cytotoxicity against the HepG2 cancer cell line in vitro, with an IC50 value of 7.5 μM [36]. Stremycins A (31) and B (32), which are two new angucycline-type antibiotics with antimicrobial activity, were obtained from the culture broth of marine Streptomyces pratensis NA-ZhouS1 by induction with high concentrations of nickel ions. They displayed antimicrobial activities against a panel of bacterial strains, including Bacillus subtillis, Pseudomonas aeruginosa, methicillin resistant Staphylococcus aureus (MRSA), Klebsiella pneumonia, and Escherichia coli, with MIC values ranging from 8 to 16 µg/mL [37]. Chen et al. isolated two new aromatic epimeric polyketides, namely wailupemycins H (33) and I (34), from the marine-derived Streptomyces sp. OUCMDZ-3434 isolated from marine algae, Enteromorpha prolifera. These compounds exhibited α-glucosidase inhibitory activity, with Ki/IC50 values of 16.8/19.7 and 6.0/8.3 μM, respectively [38]. Recently, a series of pradimicin-like polyketides, the hexaricins, including five new compounds 3539, were obtained from a marine sediment that is derived Streptosporangium sp. Of these, hexaricins F (37) and G (38) showed potent antioxidant activity, even stronger than the positive control [39]. Some researchers commonly employ co-culture as a strategy for producing novel chemistry: in a 2018 study, Zhang et al. isolated janthinopolyenemycins A (40) and B (41), which are two novel antifungal polyketides, from the co-culture of two marine-sourced bacteria Janthinobacterium spp. ZZ145 and ZZ148. These compounds displayed moderate antifungal activity against Candida albicans, with a MIC value of 15.6 μg/mL and a MBC value of 31.25 μg/mL [40].

2.2. Fungal Polyketides

Marine fungi are also major producers of diverse polyketides, with varied structures and biological activities. The chemical investigation of extracts from the marine fungus Dendrodochium sp. yielded thirteen new 12-membered macrolides, dendrodolides A–M (4254). Some of these displayed cytotoxicity against SMMC-7721 and HCT116 cells [41]. Fei He and co-workers also reported macrolides: sumalactones A–D (5558), along with two known compounds curvularin (59) and dehydrocurvularin (60), were isolated from a marine fungus Penicillium Sumatrense that was isolated from deep-sea sediments. They possessed a unique 10- or 11-membered macrolide skeleton and dehydrocurvularin displayed potent inhibitory activity against NO production, which is associated with inflammatory disorders [42]. Recently, Wu et al. isolated a group of new polyester polyketides, namely hansforesters A–M (6173), from a sponge-derived fungus Hansfordia sinuosae, of which hansforester A displayed strong inhibitory activity against a wide spectrum of bacterial strains, with MIC values of 3.9 to 15.6 µM [43].
However, aromatic polyketides with diverse biological activities are much more commonly reported from marine-derived fungi. For example, Zhang et al. identified four new tetralone derivatives, including heterodimeric clindanones A (74) and B (75) and homodimeric cladosporols F (76) and G (77) from a deep-sea isolate of the fungus Cladosporium cladosporioides HDN14-342. Cladosporol G displayed good cytotoxicity against HeLa cells, with an IC50 value of 3.9 µM [44]. Eight antifouling and antibacterial polyketides (7885), including two previously unreported examples, 6,8,5′,6′-tetrahydroxy-30-methylflavone (78) and paecilin C (79), were isolated from the gorgonian coral-associated fungus Penicillium sp. SCSGAF 0023. Compounds 78 and 8385 displayed antifouling activity against larvae settlement of Balanus amphitrite, with EC50 values of 6.7–17.9 µg/mL, while compounds 8082 showed antibacterial activity against four bacterial strains [45]. A study on the fermentation broth of the sponge-derived fungus Aspergillus sp. F40 afforded two new polyketides, versiconol B (86) and oxisterigmatocystin I (87), the former compound displayed weak antimicrobial activity against S. aureus and V. parahaemolyticus [46]. Liu et al. reported the isolations of several novel anti-inflammatory polyketides, including a pair of enantiomers (+)- and (−)-ascomindone D (88,89), which incorporate a novel 2,3-diaryl indone moiety, and two new prenylated polyketides ascomfurans C (90) and ascomarugosin A (91), from the mangrove-derived fungus Ascomycota sp. SK2YWS-L. The enantiomers displayed anti-inflammatory activities, while also inhibiting the production of NO with IC50 values of 17.0 and 17.1 µM, respectively [47]. Polyketides that were sourced from marine fungi have also proved useful in research on immunosuppressive agents. In a 2016 report, a group of polyketides (92100), including two new benzophenone derivatives, peniphenone (92), and methyl peniphenone (93), were obtained from the mangrove endophytic fungus Penicillium sp. ZJ-SY2. These compounds showed significant immunosuppressive activity, with IC50 values ranging from 5.9 to 9.3 µg/mL [48].
Many of these compounds are variations on known structure classes; however, a few highly unusual structures have been reported over the past decade. Zhu et al. isolated a new cyctotoxic hybrid polyketide, cladodionen (101) from a marine fungus Cladosporium sp. OUCMDZ-1635. It existed as a mixture of two geometric isomers and exhibited significant cytotoxicity to several cancer cells lines, with IC50 values between 9–19 µM [49]. Many of the fungal polyketides that were reported are citrinin derivatives: a novel antimitotic polyketide dicitrinone D (102) was discovered by Chen et al. from a marine sediment-derived fungus Penicillium citrinum. It showed cytotoxic activity against many tumor cells, especially the SPC-A1 cells, while not displaying significant toxicity against normal cells: several assays suggested that it was a microtubule-destabilizing agent [50]. Chemical investigation of the deep-sea-sourced Aspergillus sp. 16-02-1 afforded nine new C9 polyketides (103111), including aspiketolactonol, aspilactonols A–F, and epiaspinonediol, along with five known antibiotics. They showed inhibitory activities against a group of cancer cell lines, including K562, HL-60, HeLa, and BGC-823 [51]. Another marine mangrove-derived fungus Aspergillus ochraceus MA-15 produced three new polyketides, asperochrins A–C (112114). Among them, asperochrins A was the most effective, and it showed selective antibacterial activity against aquatic pathogenic bacteria Aeromonas hydrophila, Vibrio anguillarum, and Vibrio harveyi, with IC50 values ranging from 0.5 to 64.0 µg/mL [52]. Fang et al. isolated a new cyclopentenone, named 5-hydroxycyclopenicillone (115), from a sponge-derived fungus Trichoderma sp. HPQJ-34. Intriguingly, it displayed moderate anti-oxidative, anti-Aβ fibrillization properties, and neuroprotective effects. Overall, Chinese isolates of marine fungi have proved to be a rich source of new polyketides [53].

3. Peptides

3.1. Bacterial Peptides

Marine bacteria could produce diverse peptides, which are a group of compounds that are composed of amino acids (Figure 4). We have included in this class all compounds that are primarily amino-acid derived, which are not alkaloids. For example, Xiu et al. isolated two pumilacidin-like cyclic lipopeptides (116,117) from the marine-derived bacterium Bacillus sp. 176. Intriguingly, they showed potent motility suppression activity against marine bacterium Vibrio alginolyticus [54]. Many of the peptide compounds that were derived from marine bacteria displayed remarkable anticancer and antibacterial activity. Neo-actinomycins A and B (118,119), which are two new members of a group of well-known chromopeptides, were obtained from the marine-derived Streptomyces sp. IMB094. Neo-actinomycin A displayed nanomolar cytotoxic activities against human cancer HCT116 and A549 cell lines, with IC50 values of 38.7 and 65.8 nM, respectively. In addition, it also exhibited moderate inhibitory activities against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) strains [55]. Marine-derived Micromonospora chalcea FIM 02-523 afforded three new cyclic depsipeptides, rakicidins G–I (120122). They were composed of four unusual amino acids, with a long aliphatic chain attaching to the peptide ring. They displayed potent antitumor activities against HCT-8 and PANC-1 cancer cell lines under hypoxic conditions and also showed antibacterial activities against a panel of bacteria, with MIC values ranging from 0.125–8 µg/mL. Amongst them, rakicidin G was the most effective and it showed very strong antibacterial activity against Peptostreptococcus anaerobius ATCC 27337, with an MIC of less than 0.125 mg/mL [56]. Zhou et al. identified a highly cytotoxic depsipeptide, chromopeptide A (123), from the marine sediment-derived bacterium Chromobacterium sp. HS-13-94, which exhibited inhibitory activity against HL-60, K-562, and Ramos cells, with IC50 values of 7.7, 7.0, and 16.5 nmol/L, respectively [57].

3.2. Fungal Peptides

Marine fungi are also a major resource of biological peptides. Three new cyclopeptides, versicotides D–F (124126) were isolated from the gorgonian-derived fungus Aspergillus versicolor LZD-14-1. Versicotides E and F possessed very rare structures that have two anthranilic acid residues and a proline in a single cyclic peptide system. They showed significant lipid-lowering activities by regulating cholesterol efflux and influx [58]. Chemical investigation on the culture extracts of mangrove-derived fungus Sarocladium kiliense HDN11-112 led to the discovery of two new cyclic depsipeptides saroclides A (127) and B (128). These did not show any inhibitory activity against a series of tested cancer cells and bacterial strains, but saroclide A displayed some lipid-lowering activities. Marine fungi from Chinese waters have also been shown to produce antiviral peptides [59]. In 2017, Ma et al. isolated four new peptides, including one new cyclic pentapeptide aspergillipeptide D (129) and three linear peptides aspergillipeptides E–G (130132) from the marine gorgonian-derived fungus Aspergillus sp. SCSIO 41501, by increasing the amount of L-tryptophan in basic culture medium. Aspergillipeptides D and F exhibited potent antiviral activity against herpes simplex virus type 1 (HSV-1), with IC50 values of 9.5 and 19.8 µM, respectively [60]. The marine-derived fungus Simplicillium obclavatum EIODSF 020 that was isolated from deep-sea sediment produced a series of new linear peptides, namely simplicilliumtides A–H (133140). Among them, simplicilliumtide D showed potent antifouling activity against Bugula neritina larvae settlement [61]. In a 2012 report, Chen et al. described three new cycloheptapeptides, cordyheptapeptides C–E (141143), from the marine-derived fungus Acremonium persicinum SCSIO115. Cordyheptapeptides C and E showed cytotoxic activities against SF-268, MCF-7, and NCI-H460 cancer cell lines, with IC50 values that ranged from 2.5 to 12.1 μM [62].

4. Alkaloids

4.1. Bacterial Alkaloids

Alkaloids that are produced by marine bacteria and fungi are a large group of compounds with diverse structures and bioactivities (Figure 5; Figure 6). Amongst bacteria, alkaloids were largely reported from members of the actinomycete genus, including some novel species. For example, the chemical investigation of culture extract from a novel deep-sea actinomycete Serinicoccus profundi sp. nov. belonging to the family Intrasporangiaceae, suborder Micrococcineae, led to the discovery of 3-((6-methylpyrazin-2-yl) methyl)-1H-indole (144), a previously unreported alkaloid, which showed weak antibacterial activity against Staphylococcus aureus [63]. Another antibacterial alkaloid, streptopertusacin A (145), which is a unique indolizinium alkaloid, was obtained from the marine-derived Streptomyces sp. HZP-2216E, and it displayed moderate antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) [64]. In addition to antibacterial actives, alkaloids with antiviral activity were also obtained from marine actinomycetes. In 2013, Wang et al. isolated a new alkaloid, 2-(furan-2-yl)-6-(2S,3S,4-trihydroxybutyl) pyrazine (146), along with twelve known compounds, from the mangrove-derived actinomycete Jishengella endophytica 161111. Four of these known compounds (147150) showed antiviral activity against the influenza A virus subtype H1N1 [65]. Recently, Che et al. isolated three new anthranilate-containing alkaloids, the anthranosides A–C (151153), from the marine sponge-derived actinomycete Streptomyces sp. CMN-62. Among them, anthranoside C displayed antiviral activity against the influenza A H1N1 virus, with an IC50 value of 171 μM [66]. Another rare marine actinomycete Marinactinospora thermotolerans SCSIO 00652, belonging to the family Nocardiopsaceae, afforded six new compounds, including four new β-carboline alkaloids (154157) and two new indolactam alkaloids (158,159). They showed significant antiplasmodial activities against Plasmodium falciparum lines 3D7 and Dd2, with IC50 values ranging from 1.92 to 36.03 μM [67]. Three indole-based alkaloids, shewanellines A–C (160162), together with twelve known compounds, were discovered from the deep-sea bacterium Shewanella piezotolerans. Shewanellines C and two of the known compounds (163,164) showed potent antitumor activity against the HL-60 cell line [68]. As can be seen from above, although the amount of alkaloids derived from bacteria is not extensive, they exhibit a wide variety of activities, including antibacterial, antiviral, antiplasmodial, and anticancer properties.

4.2. Fungal Alkaloids

However, marine fungi were the most prolific source for the production of various alkaloids over the time period surveyed. Quinazoline-derived alkaloids are one of most commonly seen classes of alkaloids. In 2017, Cheng et al. reported the isolation of eleven new fumiquinazoline-type alkaloids, unique polycyclic natural products with diverse scaffolds, namely the versiquinazolines A–K (165175), from the gorgonian-derived fungus Aspergillus versicolor LZD-14-1. Some of them displayed inhibitory activities against thioredoxin reductase, with IC50 values ranging from 12 to 20 μM [69]. Subsequently, additional chemical investigation on this microbial strain by the same research group led to the discovery of another six new fumiquinazoline-type alkaloids, versiquinazolines L−Q (176181), among which versiquinazolines P and Q also showed inhibitory activity against thioredoxin reductase, with IC50 values of 13.6 μM and 12.2 μM, respectively [70]. Another fungus, Aspergillus versicolor LCJ-5-4, isolated from a marine coral, was reported to produce three new tryptophan-derived quinazolinone alkaloids, cottoquinazolines B–D (182184). Among them, Cottoquinazoline D was a unique natural product that possessed a 1-aminocyclopropane-1-carboxylic acid residue; it showed moderate inhibitory activity against Candida albicans [71]. Three new anticancer alkaloids, the auranomides A–C (185187), were discovered from the marine-derived fungus Penicillium aurantiogriseum. Auranomides A and B possessed a new scaffold that included a quinazolin-4-one that was coupled with pyrrolidin-2-iminium moiety. They displayed significant cytotoxic activity against human tumor cells, with auranomide B displaying nanomolar activity against HEPG2 cells, presenting an IC50 value of 0.097 μM/mL [72].
Piperazine-derived alkaloids, especially diketopiperazines, are another common alkaloid class discovered from marine fungi. Two new cyctotoxic epipolythiodioxopiperazines alkaloids that possessed a bridged polysulfide piperazine ring, namely chetracins E (188) and F (189), were discovered from the marine-derived fungus Acrostalagmus luteoalbus HDN13-530 by Yu et al. They exhibited remarkable cytotoxicity against a wide spectrum of cancer lines, with IC50 values ranging from 0.2 to 3.6 μM [73]. Algae-derived fungi are also an excellent source of alkaloids. Chemical investigation of the culture extract of a marine algal-derived endophytic fungus Eurotium cristatum led to the isolations of thirteen indolediketopiperazine alkaloids, as exemplified by compounds 190193. The new compound 191 displayed cytotoxic properties in a brine shrimp assay [74]. Zhang et al. reported a new 3H-oxepine-containing diketopiperazine-type alkaloid, namely varioxepine A (194), from the marine algal-derived fungus Paecilomyces variotii. It showed inhibitory activity against the plant pathogenic fungus Fusarium graminearum [75]. Five new alkaloids, including three new prenylated indole 2,5-diketopiperazine alkaloids (195197), one new indole alkaloid (198), and one new bis-benzyl pyrimidine derivative (199), the eurotiumins A–E, along with nine known analogues, were obtained from the marine-derived fungus Eurotium sp. SCSIO F452. They showed significant radical scavenging activities in a DPPH assay [76]. Marine fungi also produce indole-derived alkaloids. Recently, Li et al. isolated eight rare linearly-fused prenylated indole alkaloids that contained a pyrano[3,2-f]indole unit, named asperversiamides A–H (200207), from the marine-derived fungus Aspergillus versicolor. Asperversiamide J showed a significant inhibitory activity against NO production by inhibiting inducible nitric oxide synthase (iNOS), with an IC50 value of 5.39 μM [77]. Xu et al. reported the isolations of a group of oxindole alkaloids, including nine new compounds, namely cyclopiamides B–J (208216), from the marine fungus Penicillium commune DFFSCS026, which was isolated from a deep-sea sediment; several of these showed moderate brine shrimp lethality [78]. In a 2018 report, Zhou et al. isolated a new indole alkaloid, misszrtine A (217), from the marine sponge-derived fungus Aspergillus sp. SCSIO XWS03F03. Misszrtine A displayed remarkable inhibitory activity against HL60 and LNCaP cell lines, with IC50 values of 3.1 µM and 4.9 µM, respectively [79]. Mutant strains that were obtained from mutation of marine microbes have also provided an abundance of natural products. In 2017, Chen et al. discovered two prenylated indole alkaloids, named penicimutamides D and E (218,219), from one mutant strain of a marine-derived Penicillium purpurogenum G59 via diethyl sulfate (DES) mutagenesis. The compounds showed weak inhibitory activity against the tested cancer cell lines [80].
Some other types of alkaloids have also be obtained from marine fungi. Campyridones A–D (220223), four new pyridone alkaloids, together with a known ilicicolin, were reported from a mangrove endophytic fungus Campylocarpon sp. HDN13-307 by Li and co-workers. Campyridone D displayed cytotoxicity against HeLa cells, with IC50 values of 8.8 and 4.7 μM, respectively [81]. The mangrove endophytic fungus Diaporthe phaseolorum SKS019 afforded six new alkaloids, which included four new chromeno[3,2-c]pyridines (224227) and two new isoindolinones (228,229), along with three known compounds. Among them, the known compounds 230, 231 showed potent anticancer activity against MDA-MB-435, HCT116, and NCI-H460 human cancer cell lines [82]. Shao et al. isolated a new pyrrolyl 4-quinolinone alkaloid that possessed an unprecedented ring system, namely penicinoline (232), from a mangrove endophytic fungus Penicillium sp. It displayed inhibitory activity against 95-D and HepG2 cell lines, with IC50 values of 0.57 and 6.5 µg/mL, respectively [83].
Marine microbes also produce some truly unusual alkaloid compounds. Aspeverin A (233), which is a novel carbamate- and cyano-containing alkaloid, was reported from the marine fungus Aspergillus versicolor strain that was isolated from a green alga. It showed potent inhibitory activity against phytoplankton (Heterosigma akashiwo), with EC50 values of 6.3 and 3.4 μg/mL after 24 and 96 h, respectively [84]. A study regarding the chemical constituents of a culture extract from the marine fungus Chaetomium globosum led to the discovery of two new cytochalasan alkaloids, namely cytoglobosins H (234) and I (235), along with seven analogues. Among them, chaetoglobosin E (236) exhibited strong antiproliferative activity against LNCaP and B16F10 cell lines, with IC50 values of 0.62 and 2.78 µM, respectively [85]. Subsequently, in a 2017 report, Zhu et al. discovered another new chaetoglobosin, penochalasin K (237), which contained a fused ring system, from the mangrove endophytic fungus Penicillium chrysogenum V11. It showed moderate antimicrobial activities against Colletotrichum gloeosporioides and Rhizoctonia solani, with MIC values of 6.13 and 12.26 μM, respectively, in addition to moderate activity against a panel of cancer cell lines [86]. Another potent antitumor alkaloid agent, penicitrinine A (238), which possessed a unique spiro skeleton, was discovered from the marine fungus Penicillium citrinum. It showed inhibitory activities against multiple tumor types, especially on human malignant melanoma cell A-375 [87]. In a 2014 report, He et al. obtained a new unusual alkaloid, named penicilliumine (239), from the marine-derived fungus Penicillium commune 366606. It existed as a racemic mixture of (−)-penicilliumine and (+)-penicilliumine, and showed inhibitory activity against acetylcholinesterase [88].

5. Terpenoids, Terpenes and Meroterpenoids

Marine fungi could also produce a variety of structurally different terpenoid compounds with interesting biological activities, such as eremophilane-type and carotene-type sesquiterpene, bisabolane-type sesquiterpenoids, eudesmane-type sesquiterpenoids, pimarane-type diterpenes, and other types, which have been widely reported by Chinese researchers (Figure 7 and Figure 8). Amongst them, multiple types of sesquiterpenoid or sesquiterpene compounds are most commonly observed.
Chemical investigation on the culture extract of sponge-associated fungus Hansfordia sinuosae afforded six new caryophyllene-type sesquiterpenoids that possess a unique bicyclo[2.7.0]undecane skeleton, named punctaporonins H–M (240245). Among them, punctaporonins K showed potent lipid-lowering activity that could reduce the intracellular levels of triglycerides and total cholesterol [89]. Another sponge-derived fungus Aspergillus sp. afforded four new antibacterial bisabolane-type sesquiterpenoids (246249). They showed either broad spectrum or selective antibacterial activity against the eight tested bacterial strains [90]. Some sesquiterpenoids also exhibit significant anticancer activities. Fang et al. isolated a highly unusual nitrobenzoyl sesquiterpenoid, 6b,9a-dihydroxy-14-p-nitrobenzoylcinnamolide (250), together with a known analogue, insulicolide A (251), from the marine-derived fungus Aspergillus ochraceus Jcma1F17. These both displayed significant anticancer activity against a panel of cancer cell lines, while 251 also displayed antiviral activities against H3N2 and EV71 [91]. The mangrove-derived endophytic fungus Penicillium sp. J-54 afforded four new eudesmane-type sesquiterpenoids, namely penicieudesmol A–D (252255). Among them, penicieudesmol B displayed weak cytotoxicity against K-562 cells [92]. Li et al. isolated five new triquinane-type sesquiterpenoids, namely chondrosterins A–E (256260), from the soft coral-associated fungus Chondrostereum sp. Chondrosterin A showed low micromolar cytotoxic activities against the cancer lines A549, CNE2, and LoVo [93].
Chromatographic separation of the culture extract from the sponge-associated fungus Stachybotrys chartarum led to the isolations of a group of cytotoxic trichothecene-type sesquiterpenes, including four previously unreported ones, namely chartarenes A–D (261264). They exhibited potent antitumor activity against a panel of tumor cell lines, including HCT-116 and HepG2, with IC50 values < 10 μg/mL, in addition to inhibitory activity against tumor growth-related tyrosine kinases, including FGFR3, IGF1R, PDGFRb, and TRKB [94]. Chemical investigation of the marine fungus Trichoderma virens, which was isolated from marine red alga, led to the discovery of eight new carotane sesquiterpenes, named trichocarotins A–H (265272), and one new cadinane sesquiterpene, named trichocadinin A (273), some of which showed inhibitory activity against the growth of some marine plankton species [95]. Dendryphiellins H–J (274276), three new eremophilane sesquiterpenes, were isolated from the marine-derived fungus Cochliobolus lunatus SCSIO41401. Dendryphiellin I displayed significant cytotoxicities against five cancer cell lines, with an IC50 value of 1.4 to 4.3 μM, in addition to antibacterial activities against bacterial species, with MIC values of 1.5 to 13 μg/mL, respectively. The unusual aldoximine derivative dendryphiellin J also showed potent cytotoxicities against ACHN and HepG-2 cells, with IC50 values of 3.1 and 5.9 μM, respectively [96]. The marine-derived fungus Penicillium bilaiae MA-267 provided two novel sesquiterpenes (277,278) that possessed a tricyclo[6.3.1.01,5]dodecane skeleton, they showed activity against the plant pathogenic fungus Colletotrichum gloeosporioides [97]. While the majority of terpenes from marine-derived microbes come from fungi, a few have been reported from bacteria. One example is a new caged sesquiterpene, named strepsesquitriol (279), which was isolated from the marine-derived actinomycete Streptomyces sp. SCSIO 10355, which showed moderate inhibitory activity against lipopolysaccharide-stimulated tumor necrosis factor (TNFα) production in RAW264.7 macrophages [98].
In addition to sesquiterpenes, diterpenes were also obtained from marine fungi in many instances. In 2018, Song et al. isolated six new terpenes, including one harziane diterpene (280), one proharziane diterpene (281), three cyclonerane sesquiterpene (282284), and one acrorane sesquiterpene (285), from the marine fungus Trichoderma harzianum X-5 isolated from a marine brown alga. They exhibited inhibitory activity against some marine phytoplankton species [99]. Pimarane diterpenes are a widely distributed class of terpenes that are produced by a wide variety of organisms, and marine-derived fungi are no exception [100]. In 2012, Sun et al. reported the isolations of five new oxygenated pimarane diterpenes, named scopararanes C–G (286290), from a marine sediment-derived fungus Eutypella scoparia FS26. Scopararanes C and D showed moderate cytotoxic activities against the MCF-7 tumor cell line [101]. Later, another two new pimarane-type diterpenes, scopararanes H and I (291,292), were isolated from the same research group as the marine sediment-derived fungus Eutypella sp. FS46. Scopararane I showed moderate inhibitory activities against the tested tumor cell lines [102]. Another sediment-derived fungus, Aspergillus wentii SD-310, provided a wealth of new diterpenoid compounds, including two new tetranorlabdane diterpenoids, named asperolides D (293) and E (294), six new isopimarane-type diterpenoid derivatives, named wentinoids A–F (295300), and four new uncommon 20-nor-isopimarane diterpenoid epimers, aspewentins I–L (301304). Some of them exhibited promising selective anticancer or antimicrobial activity [103,104,105].
Aspergillus species have been shown to be a particularly rich source of terpenoid compounds, including sesterterpenoids: Asperterpenoid A (305), a novel pentacyclic sesterterpenoid, was discovered from a mangrove endophytic fungus Aspergillus sp. 16-5c. It showed strong inhibitory activity against Mycobacterium tuberculosis protein tyrosine phosphatase B (mPTPB), with an IC50 value of 2.2 μM [106]. Later, the mangrove endophytic fungus Aspergillus sp. 085242 afforded another two similar sesterterpenoids with an unusual 5/8/6/6 tetracyclic ring skeleton, which were named asperterpenols A (306) and B (307). In contrast to asperterpenoid A, they showed potent acetylcholinesterase (AChE) inhibitory activity, with IC50 values of 2.3 and 3.0 μM, respectively [107].
Meroterpenes and meroterpenoids are also commonly seen compounds that are produced by marine microbes. They are hybrid natural products assembled by terpene or terpenoids moieties with other precursors, such as polyketide [108], and they display a diverse range of useful biological activities, as exemplified below. Chemical investigation of the culture extract from the marine fungus Alternaria alternata k21-1 isolated from a marine alga afforded a new sesterterpene, named sesteralterin (308), and four new meroterpenes, named tricycloalterfurenes A–D (309312). Some of them showed selective inhibitory activity against phytoplankton [109]. Brasilianoids A–F (313318), six new meroterpenoids, were reported from the sponge-associated fungus Penicillium brasilianum in 2018. Brasilianoid A could significantly stimulate the expression of filaggrin and caspase-14 in HaCaT cells in a dose-dependent manner, while brasilianoids B and C showed moderate inhibitory activity against NO production in LPS-induced RAW 264.7 macrophages [110]. Chen et al. isolated four anti-inflammatory meroterpenoids, named amestolkolides A–D (319322), from the mangrove endophytic fungus Talaromyces amestolkiae YX1. Among them, amestolkolides B showed anti-inflammatory activity against LPS-activated NO production in RAW264.7 cells in vitro, with IC50 value of 1.6 μM [111]. Meroterpenoids have also shown good activity in antiviral assays: the sponge-derived fungus Aspergillus aureolatus HDN14-107 generated three new meroterpenoids, named austalides S-U (323325). Austalides U displayed inhibitory activity against influenza virus A (H1N1) [112]. In 2017, Zhang et al. isolated six new meroterpenoids, named stachybonoids A–F (326331), together with three known phenylspirodrimanes, from the crinoid-derived fungus Stachybotrys chartarum 952. Among them, stachybonoid A showed inhibitory activity against the replication of dengue virus, while stachybonoid F showed anti-inflammatory activity against LPS-activated NO production in RAW264.7 cells [113].

6. Mixed-Structure Compounds

Many of the secondary metabolites from marine-derived microbes are structurally hybrid compounds (Figure 9), similar to the meroterpenoids mentioned earlier. In 2013, Liu et al. isolated two new oxazole-thiazole siderophores, namely tetroazolemycins A (332) and B (333), from a Streptomyces olivaceus strain, isolated from deep-sea water. They showed an affinity for a range of cations, including Fe3+, Cu2+, and Zn2+ [114]. Chemical investigation of culture extract of a sponge-derived fungus Alternaria sp. afforded two new altenusin-thiazole hybrids, named altenusinoides A (334) and B (335), along with three known compounds. Amongst them, the known compounds 336337 showed DPPH free-radical-scavenging activities; 337 also showed COX-2 inhibitory activity [115]. Chen et al. identified four new chromenopyridine derivatives, phochrodines A–D (338341), from the mangrove entophytic fungus Phomopsis sp. 33#. Phochrodines B and D showed inhibitory activity against NO production, while phochrodine D also exhibited DPPH free-radical-scavenging activities [116].

7. Other Compounds

Marine microbes have also been shown to produce compounds that cannot easily be assigned to a particular structure class; these are briefly discussed here. In a 2018 report, Sun et al. isolated a group of butenolide derivatives, including two new compounds (342,343) from a marine sponge-derived fungus Aspergillus terreus. They displayed potent inhibitory activities against α-glucosidase [117]. Chemical investigation of culture extract of another marine fungus, Aspergillus niger, led to the discovery of three new itaconic acid derivatives, namely asperitaconic acids A–C (344346). They showed inhibitory activity against Staphylococcus aureus, with MIC values of 16–32 μg/mL [118]. Tunicamycin E (347), a new nucleoside antibiotic, along with six analogues, was obtained from the marine-derived Streptomyces xinghaiensis SCSIO S15077. They displayed moderate antifungal activity against two Candida albicans strains, and very strong inhibitory activity against Bacillus thuringiensis, with MIC values of 0.008–2 μg/mL [119]. Huang et al. obtained one 1-deoxy-N-acetylglucosamine compound (348) from a marine bacterium Virgibacillus dokdonensis MCCC 1A00493 isolated from deep-sea polymetallic nodules. It displayed significant inhibitory activity against Xanthomonas oryzae pv. oryzae, which is a pathogenic bacteria causing rice bacterial blight [120]. In a few instances, the reports describe the isolation of new compounds from multiple structure classes: Chen et al. isolated six steroid derivatives, including a new one (349), together with five butyrolactone derivatives, from a gorgonian-derived fungus Aspergillus sp. Some of them showed antifouling activity against larval settlement of the barnacle Balanus amphitrite and antibacterial activity against Staphylococcus aureus [121].

8. Discussion

A total of 897 papers describing the isolation of biologically active compounds from marine-derived microbes were analyzed for this review (Supplementary Table S1). One of the most notable and immediately apparent trends is the dramatic increase in the number of China-based publications focusing on the chemistry of marine microbes over the past decade. A mere 22 papers on the topic were published in English-language journals in 2009, which has increased more than sevenfold over the past decade, with 176 papers being published in 2018 (Figure 10a). This increase may be due to increasing numbers of groups conducting this research, or it might represent a shift from publication in local Chinese journals to international journals. The overwhelming focus on fungi is also clear, with 80% of all reports describing the isolation of bioactive compounds from fungi, 16% from actinomycetes, and only 4% from other bacteria (Figure 10b); there does not appear to be any consistent change in this composition over the 10 years that were monitored for this review.
The major venue for publication has been Marine Drugs (166 publications, 18.5%), followed by the Journal of Natural Products (115 publications, 12.8%) and Natural Product Research (75, 8.4%) (Figure 10c). Given the subject material, the popularity of the former is very understandable, while the latter two also strongly featured in a 2018 review on China-based natural products research from all sources [15]. Other popular journals included Tetrahedron (42, 4.7%), Chemistry of Natural Compounds (37, 4.1%), the Journal of Antibiotics (34, 3.8%), Organic Letters (33, 3.7%), and RSC Advances (33, 3.7%).
Marine sediments were the most popular location for the collection of microbial strains (289 papers, 32%), though endophytic microbes from plants (253, 28%), invertebrates (225, 25%), and algae (67, 7.4%) were also popular (Figure 10d). While marine algae and invertebrates are a common source of microbial endophytes in many countries, marine plants are not so. Their popularity in China can be largely attributed to the presence of several research groups focusing on the chemistry of mangrove endophytes, in particular, fungi, which can be a rich source of novel chemistry [23,122,123].
In terms of structure class, examples of the various structural classes has been discussed in depth above, but it was clear that polyketides made up the largest proportion of new and active compounds reported (332, 37%), distantly followed by alkaloids (138, 15%) and terpenes (131, 15%) (Figure 10e); compounds with mixed biosynthetic origin (92, 10%) were also well represented. Several papers reported the isolation of multiple new, active compounds from two or more structure classes simultaneously (63, 7%). For biological activity, the focus of research was overwhelmingly on anti-bacterial (270) and cytotoxic activity (417), which were reported by numerous researchers (Figure 10f). However, reports on more specialized biological assays tended to be associated with particular research groups. For example, the majority of reports on alpha-glucosidase inhibitors (34 papers) were reported by Zhigang She and coworkers, while antifouling activity (32 papers) was a particular focus of Changyun Wang and co-workers in Qingdao. Likewise, most of the reports on anti-algal agents came out of the Chinese Academy of Sciences in Yantai. A large number of other biological activities were also reported in smaller numbers, often including the ability of compounds to inhibit enzyme systems, such as acetylcholinesterase, COX-2, or various kinases.
Overall, this review illustrates the diversity of research being conducted by China-based research in the field of marine microbial natural products drug discovery, while the increasing pace of publication suggests that China will continue to be a major player in the field over the years to come.

9. Methodology

For the purposes of this review, only papers reporting the isolation of compounds with biological activity were reported. The scope of the review was limited to SCI-indexed journals. Only papers with at least one corresponding author based in China are included. Most of the papers reviewed reported active new compounds, but papers the reporting known compounds were also included, provided that the compounds possessed significant new activity. A full list of papers summarized in the review is given in Supplementary Table S1. For collection location, most of the categories are self-explanatory, however, ‘sediment’ encompassed both marine sediment, material from beaches, or even soil in a high salt environment (e.g., around mangroves). For biological activity: antioxidant activity also includes radical scavengers; anti-fouling activity incorporates biofilm inhibition; and “cytotoxic” includes compounds active against both cancerous and non-cancerous cell lines. Structural classifications are assigned for the new compounds isolated, or, if no new compounds were reported, for the active compounds. This was carried out by (a) accepting the classification of the author, if one was given, (b) checking if biosynthesis was known for the compound or structure class, or (c) careful observation of the structures. Heterologous expression studies, or compounds that were isolated from mutant strains produced by specific molecular manipulations were not included, but the mutant strains produced by other methods were included in the review.

Supplementary Materials

The following are available online at https://www.mdpi.com/1660-3397/17/6/339/s1, Table S1 containing all references surveyed for the Discussion section of this review.

Author Contributions

Conceptualization, B.R.C. and W.S.; methodology, B.R.C.; validation, B.R.C; investigation, W.W., X.L. and W.S.; writing—original draft preparation, W.S. and D.A.Z.-P.; writing—review and editing, B.R.C. and D.A.Z.-P.; visualization, W.W., X.L., B.R.C. and W.S.; funding acquisition, B.R.C.

Funding

This research was funded in part by the award from the Research Fund for International Young Scientists (81850410550) from the National Natural Science Foundation of China (NSFC).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Cragg, G.M.; Newman, D.J.; Snader, K.M. Natural products in drug discovery and development. J. Nat. Prod. 1997, 3864, 52–60. [Google Scholar] [CrossRef] [PubMed]
  2. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the period 1981–2002. J. Nat. Prod. 2003, 1022–1037. [Google Scholar] [CrossRef] [PubMed]
  3. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70, 461–477. [Google Scholar] [CrossRef] [PubMed]
  4. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311–335. [Google Scholar] [CrossRef] [PubMed]
  5. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016, 79, 629–661. [Google Scholar] [CrossRef]
  6. Demain, A.L. Importance of microbial natural products and the need to revitalize their discovery. J. Ind. Microbiol. Biotechnol. 2014, 41, 185–201. [Google Scholar] [CrossRef]
  7. Knight, V.; Sanglier, J.J.; DiTullio, D.; Braccili, S.; Bonner, P.; Waters, J.; Hughes, D.; Zhang, L. Diversifying microbial natural products for drug discovery. Appl. Microbiol. Biotechnol. 2003, 62, 446–458. [Google Scholar] [CrossRef]
  8. Carrano, L.; Marinelli, F. The relevance of chemical dereplication in microbial natural product screening. J. Appl. Bioanal. 2015, 1, 55–67. [Google Scholar] [CrossRef]
  9. Handelsmanl, J.; Rondon, M.R.; Goodman, R.M.; Brady, S.F.; Clardy, J. Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chem. Biol. 1998, 5, 245–249. [Google Scholar] [CrossRef]
  10. Pan, R.; Bai, X.; Chen, J.; Zhang, H.; Wang, H. Exploring structural diversity of microbe secondary metabolites using OSMAC strategy: A literature review. Front. Microbiol. 2019, 10. [Google Scholar] [CrossRef]
  11. Sekurova, O.N.; Schneider, O.; Zotchev, S.B. Minireview Novel bioactive natural products from bacteria via bioprospecting, genome mining and metabolic engineering. Microb. Biotechnol. 2019. [Google Scholar] [CrossRef] [PubMed]
  12. Schmidt-Dannert, C. NextGen microbial natural products discovery. Microb. Biotechnol. 2015, 8, 26–28. [Google Scholar] [CrossRef] [PubMed]
  13. Wang, M.; Carver, J.J.; Phelan, V.V.; Sanchez, L.M.; Garg, N.; Peng, Y.; Nguyen, D.D.; Watrous, J.; Kapono, C.A.; Luzzatto-Knaan, T.; et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 2016, 34, 828–837. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Pye, C.R.; Bertin, M.J.; Lokey, R.S.; Gerwick, W.H.; Linington, R.G. Retrospective analysis of natural products provides insights for future discovery trends. Proc. Natl. Acad. Sci. USA 2017, 114, 5601–5606. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Liu, H.; Zhu, G.; Fan, Y.; Du, Y.; Lan, M.; Xu, Y.; Zhu, W. Natural products research in China from 2015 to 2016. Front. Chem. 2018, 6, 45. [Google Scholar] [CrossRef] [PubMed]
  16. Kong, L.Y.; Tan, R.X. Artemisinin, a miracle of traditional Chinese medicine. Nat. Prod. Rep. 2015, 32, 1617–1621. [Google Scholar] [CrossRef] [PubMed]
  17. Patwardhan, B.; Warude, D.; Pushpangadan, P.; Bhatt, N. Ayurveda and traditional Chinese medicine: A comparative overview. Evidence-Based Complement. Altern. Med. 2005, 2, 465–473. [Google Scholar] [CrossRef]
  18. Wang, Q.; Hu, Z.; Li, X.; Wang, A.; Wu, H.; Liu, J.; Cao, S.; Liu, Q. Salviachinensines A–F, Antiproliferative phenolic derivatives from the Chinese medicinal plant Salvia chinensis. J. Nat. Prod. 2018, 81, 2531–2538. [Google Scholar] [CrossRef]
  19. Sun, N.; Zhu, Y.; Zhou, H.; Zhou, J.; Zhang, H.; Zhang, M.; Zeng, H.; Yao, G. Grayanane diterpenoid glucosides from the leaves of Rhododendron micranthum and their bioactivities evaluation. J. Nat. Prod. 2018, 81, 2673–2681. [Google Scholar] [CrossRef]
  20. Zhao, C.; Zhu, T.; Zhu, W. New marine natural products of microbial origin from 2010 to 2013. Chinese J. Org. Chem. 2013, 33, 1195–1234. [Google Scholar] [CrossRef]
  21. Li, Z. Advances in marine microbial symbionts in the China Sea and related pharmaceutical metabolites. Mar. Drugs 2009, 8, 113–129. [Google Scholar] [CrossRef] [PubMed]
  22. Xiong, Z.Q.; Wang, J.F.; Hao, Y.Y.; Wang, Y. Recent advances in the discovery and development of marine microbial natural products. Mar. Drugs 2013, 11, 700–717. [Google Scholar] [CrossRef] [PubMed]
  23. Wang, X.; Mao, Z.G.; Song, B.B.; Chen, C.H.; Xiao, W.W.; Hu, B.; Wang, J.W.; Jiang, X.B.; Zhu, Y.H.; Wang, H.J. Advances in the study of the structures and bioactivities of metabolites isolated from mangrove-derived fungi in the South China Sea. Mar. Drugs 2013, 11, 3601–3616. [Google Scholar] [CrossRef] [PubMed]
  24. Kang, Q.; Bai, L.; Deng, Z. Toward steadfast growth of antibiotic research in China: From natural products to engineered biosynthesis. Biotechnol. Adv. 2012, 30, 1228–1241. [Google Scholar] [CrossRef] [PubMed]
  25. Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2009, 26, 170–244. [Google Scholar] [CrossRef] [PubMed]
  26. Carroll, A.R.; Copp, B.R.; Davis, R.A.; Keyzers, R.A.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2019, 36, 122–173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Shinde, P.; Banerjee, P.; Mandhare, A. Marine natural products as source of new drugs: A patent review (2015–2018). Expert Opin. Ther. Pat. 2019, 4, 283–309. [Google Scholar] [CrossRef] [PubMed]
  28. Khosla, C. Structures and mechanisms of polyketide synthases. J. Org. Chem. 2009, 74, 6416–6420. [Google Scholar] [CrossRef]
  29. Gao, C.H.; Tian, X.P.; Qi, S.H.; Luo, X.M.; Wang, P.; Zhang, S.J. Antibacterial and antilarval compounds from marine gorgonian-associated bacterium Bacillus amyloliquefaciens SCSIO 00856. J. Antibiot. (Tokyo) 2010, 63, 191–193. [Google Scholar] [CrossRef]
  30. Wu, C.; Tan, Y.; Gan, M.; Wang, Y.; Guan, Y.; Hu, X.; Zhou, H.; Shang, X.; You, X.; Yang, Z.; et al. Identification of elaiophylin derivatives from the marine-derived actinomycete Streptomyces sp. 7-145 using PCR-based screening. J. Nat. Prod. 2013, 76, 2153–2157. [Google Scholar] [CrossRef]
  31. Song, Y.; Li, Q.; Qin, F.; Sun, C.; Liang, H.; Wei, X.; Wong, N.K.; Ye, L.; Zhang, Y.; Shao, M.; et al. Neoabyssomicins A–C, polycyclic macrolactones from the deep-sea derived Streptomyces koyangensis SCSIO 5802. Tetrahedron 2017, 73, 5366–5372. [Google Scholar] [CrossRef]
  32. Huang, H.; Song, Y.; Li, X.; Wang, X.; Ling, C.; Qin, X.; Zhou, Z.; Li, Q.; Wei, X.; Ju, J. Abyssomicin monomers and dimers from the marine-derived Streptomyces koyangensis SCSIO 5802. J. Nat. Prod. 2018, 81, 1892–1898. [Google Scholar] [CrossRef]
  33. Jiang, S.; Zhang, L.; Pei, X.; Deng, F.; Hu, D.; Chen, G.; Wang, C.; Hong, K.; Yao, X.; Gao, H. Chalcomycins from marine-derived Streptomyces sp. and their antimicrobial activities. Mar. Drugs 2017, 15, 153. [Google Scholar] [CrossRef]
  34. Nong, X.H.; Zhang, X.Y.; Xu, X.Y.; Wang, J.; Qi, S.H. Nahuoic Acids B–E, Polyhydroxy polyketides from the marine-derived Streptomyces sp. SCSGAA 0027. J. Nat. Prod. 2016, 79, 141–148. [Google Scholar] [CrossRef]
  35. Gong, T.; Zhen, X.; Li, X.L.; Chen, J.J.; Chen, T.J.; Yang, J.L.; Zhu, P. Tetrocarcin Q, a new spirotetronate with a unique glycosyl group from a marine-derived actinomycete Micromonospora carbonacea LS276. Mar. Drugs 2018, 16, 74. [Google Scholar] [CrossRef]
  36. Gan, M.; Liu, B.; Tan, Y.; Wang, Q.; Zhou, H.; He, H.; Ping, Y.; Yang, Z.; Wang, Y.; Xiao, C. Saccharothrixones A–D, tetracenomycin-type polyketides from the marine-derived actinomycete Saccharothrix sp. 10-10. J. Nat. Prod. 2015, 78, 2260–2265. [Google Scholar] [CrossRef]
  37. Akhter, N.; Liu, Y.; Auckloo, B.N.; Shi, Y.; Wang, K.; Chen, J.; Wu, X.; Wu, B. Stress-driven discovery of new angucycline-type antibiotics from a marine Streptomyces pratensis NA-ZhouS1. Mar. Drugs 2018, 16, 331. [Google Scholar] [CrossRef]
  38. Chen, Z.; Hao, J.; Wang, L.; Wang, Y.; Kong, F.; Zhu, W. New α-glucosidase inhibitors from marine algae-derived Streptomyces sp. OUCMDZ-3434. Sci. Rep. 2016, 6, 20004. [Google Scholar] [CrossRef]
  39. Gao, C.; Guo, Z.; Lu, X.; Chen, H.; Liu, L.; Yu, Z.; Chen, Y. Hexaricins, pradimicin-like polyketides from a marine sediment-derived Streptosporangium sp. and their antioxidant effects. J. Nat. Prod. 2018, 81, 2069–2074. [Google Scholar] [CrossRef]
  40. Anjum, K.; Sadiq, I.; Chen, L.; Kaleem, S.; Li, X.C.; Zhang, Z.; Lian, X.Y. Novel antifungal janthinopolyenemycins A and B from a co-culture of marine-associated Janthinobacterium spp. ZZ145 and ZZ148. Tetrahedron Lett. 2018, 59, 3490–3494. [Google Scholar] [CrossRef]
  41. Sun, P.; Xu, D.X.; Mándi, A.; Kurtán, T.; Li, T.J.; Schulz, B.; Zhang, W. Structure, absolute configuration, and conformational study of 12-membered macrolides from the fungus Dendrodochium sp. associated with the sea cucumber Holothuria nobilis Selenka. J. Org. Chem. 2013, 78, 7030–7047. [Google Scholar] [CrossRef]
  42. Wu, Y.H.; Zhang, Z.H.; Zhong, Y.; Huang, J.J.; Li, X.X.; Jiang, J.Y.; Deng, Y.Y.; Zhang, L.H.; He, F. Sumalactones A-D, four new curvularin-type macrolides from a marine deep sea fungus: Penicillium sumatrense. RSC Adv. 2017, 7, 40015–40019. [Google Scholar] [CrossRef]
  43. Wu, Z.; Liu, D.; Huang, J.; Proksch, P.; Zhu, K.; Lin, W. Hansforesters A–M, polyesters from the sponge-associated fungus Hansfordia sinuosae with antibacterial activities. RSC Adv. 2018, 8, 39756–39768. [Google Scholar] [CrossRef]
  44. Zhang, Z.; He, X.; Liu, C.; Che, Q.; Zhu, T.; Gu, Q.; Li, D. Clindanones A and B and cladosporols F and G, polyketides from the deep-sea derived fungus: Cladosporium cladosporioides HDN14-342. RSC Adv. 2016, 6, 76498–76504. [Google Scholar] [CrossRef]
  45. Bao, J.; Sun, Y.L.; Zhang, X.Y.; Han, Z.; Gao, H.C.; He, F.; Qian, P.Y.; Qi, S.H. Antifouling and antibacterial polyketides from marine gorgonian coral-associated fungus Penicillium sp. SCSGAF 0023. J. Antibiot. (Tokyo) 2013, 66, 219–223. [Google Scholar] [CrossRef]
  46. Tian, Y.Q.; Lin, S.T.; Kumaravel, K.; Zhou, H.; Wang, S.Y.; Liu, Y.H. Polyketide-derived metabolites from the sponge-derived fungus Aspergillus sp. F40. Phytochem. Lett. 2018, 27, 74–77. [Google Scholar] [CrossRef]
  47. Liu, Z.; Qiu, P.; Li, J.; Chen, G.; Chen, Y.; Liu, H.; She, Z. Anti-inflammatory polyketides from the mangrove-derived fungus Ascomycota sp. SK2YWS-L. Tetrahedron 2018, 74, 746–751. [Google Scholar] [CrossRef]
  48. Liu, H.; Chen, S.; Liu, W.; Liu, Y.; Huang, X.; She, Z. Polyketides with immunosuppressive activities from mangrove endophytic fungus Penicillium sp. ZJ-SY2. Mar. Drugs 2016, 14, 1–7. [Google Scholar] [CrossRef]
  49. Zhu, G.; Kong, F.; Wang, Y.; Fu, P.; Zhu, W. Cladodionen, a cytotoxic hybrid polyketide from the marine-derived Cladosporium sp. OUCMDZ-1635. Mar. Drugs 2018, 16, 71. [Google Scholar] [CrossRef]
  50. Chen, L.; Zhao, Y.Y.; Lan, R.F.; Du, L.; Wang, B.S.; Zhou, T.; Li, Y.P.; Zhang, Q.Q.; Ying, M.G.; Zheng, Q.H.; et al. Dicitrinone D, an antimitotic polyketide isolated from the marine-derived fungus Penicillium citrinum. Tetrahedron 2017, 73, 5900–5911. [Google Scholar] [CrossRef]
  51. Chen, X.W.; Li, C.W.; Cui, C.B.; Hua, W.; Zhu, T.J.; Gu, Q.Q. Nine new and five known polyketides derived from a deep sea-sourced Aspergillus sp. 16-02-1. Mar. Drugs 2014, 12, 3116–3137. [Google Scholar] [CrossRef]
  52. Liu, Y.; Li, X.M.; Meng, L.H.; Wang, B.G. Polyketides from the marine mangrove-derived fungus Aspergillus ochraceus MA-15 and their activity against aquatic pathogenic bacteria. Phytochem. Lett. 2015, 12, 232–236. [Google Scholar] [CrossRef]
  53. Fang, F.; Zhao, J.; Ding, L.; Huang, C.; Naman, C.B.; He, S.; Wu, B.; Zhu, P.; Luo, Q.; Gerwick, W.H.; et al. 5-Hydroxycyclopenicillone, a new β-amyloid fibrillization inhibitor from a sponge-derived fungus Trichoderma sp. HPQJ-34. Mar. Drugs 2017, 15, 260. [Google Scholar] [CrossRef]
  54. Xing, P.Y.; Liu, R.; Zhang, D.C.; SUN, C.M. Pumilacidin-like lipopeptides derived from marine bacterium Bacillus sp. Strain 176 suppress the motility of Vibrio alginolyticus. Appl. Environ. Microbiol. 2017, 83, e00450-17. [Google Scholar]
  55. Wang, Q.; Zhang, Y.; Wang, M.; Tan, Y.; Hu, X.; He, H.; Xiao, C.; You, X.; Wang, Y.; Gan, M. Neo-actinomycins A and B, natural actinomycins bearing the 5H-oxazolo[4,5-b]phenoxazine chromophore, from the marine-derived Streptomyces sp. IMB094. Sci. Rep. 2017, 7, 4–11. [Google Scholar] [CrossRef]
  56. Chen, L.; Zhao, W.; Jiang, H.L.; Zhou, J.; Chen, X.M.; Lian, Y.Y.; Jiang, H.; Lin, F. Rakicidins G–I, cyclic depsipeptides from marine Micromonospora chalcea FIM 02-523. Tetrahedron 2018, 74, 4151–4154. [Google Scholar] [CrossRef]
  57. Zhou, Z.; Wang, X.; Zhang, H.; Sun, J.; Zheng, L.; Liu, H.; Wang, J.; Shen, A.; Geng, M.; Guo, Y. Chromopeptide A, a highly cytotoxic depsipeptide from the marine sediment-derived bacterium Chromobacterium sp. HS-13-94. Acta Pharm. Sin. B 2015, 5, 62–66. [Google Scholar] [CrossRef]
  58. Chen, R.; Cheng, Z.; Huang, J.; Liu, D.; Wu, C.; Guo, P.; Lin, W. Versicotides D–F, new cyclopeptides with lipid-lowering activities. RSC Adv. 2017, 7, 49235–49243. [Google Scholar] [CrossRef]
  59. Guo, W.; Wang, S.; Li, N.; Li, F.; Zhu, T.; Gu, Q.; Guo, P.; Li, D. Saroclides A and B, cyclic depsipeptides from the mangrove-derived fungus Sarocladium kiliense HDN11-112. J. Nat. Prod. 2018, 81, 1050–1054. [Google Scholar] [CrossRef]
  60. Ma, X.; Nong, X.H.; Ren, Z.; Wang, J.; Liang, X.; Wang, L.; Qi, S.H. Antiviral peptides from marine gorgonian-derived fungus Aspergillus sp. SCSIO 41501. Tetrahedron Lett. 2017, 58, 1151–1155. [Google Scholar] [CrossRef]
  61. Liang, X.; Zhang, X.Y.; Nong, X.H.; Wang, J.; Huang, Z.H.; Qi, S.H. Eight linear peptides from the deep-sea-derived fungus Simplicillium obclavatum EIODSF 020. Tetrahedron 2016, 72, 3092–3097. [Google Scholar] [CrossRef]
  62. Chen, Z.; Song, Y.; Chen, Y.; Huang, H.; Zhang, W.; Ju, J. Cyclic heptapeptides, cordyheptapeptides C–E, from the marine-derived fungus Acremonium persicinum SCSIO 115 and their cytotoxic activities. J. Nat. Prod. 2012, 75, 1215–1219. [Google Scholar] [CrossRef]
  63. Yang, X.W.; Zhang, G.Y.; Ying, J.X.; Yang, B.; Zhou, X.F.; Steinmetz, A.; Liu, Y.H.; Wang, N. Isolation, characterization, and bioactivity evaluation of 3-((6-methylpyrazin-2-yl)methyl)-1H-indole, a new alkaloid from a deep-sea-derived actinomycete Serinicoccus profundi sp. nov. Mar. Drugs 2013, 11, 33–39. [Google Scholar] [CrossRef]
  64. Zhang, X.; Chen, L.; Chai, W.; Lian, X.Y.; Zhang, Z. A unique indolizinium alkaloid streptopertusacin A and bioactive bafilomycins from marine-derived Streptomyces sp. HZP-2216E. Phytochemistry 2017, 144, 119–126. [Google Scholar] [CrossRef]
  65. Wang, P.; Kong, F.; Wei, J.; Wang, Y.; Wang, W.; Hong, K.; Zhu, W. Alkaloids from the mangrove-derived actinomycete Jishengella endophytica 161111. Mar. Drugs 2014, 12, 477–490. [Google Scholar] [CrossRef]
  66. Che, Q.; Qiao, L.; Han, X.; Liu, Y.; Wang, W.; Gu, Q.; Zhu, T.; Li, D. Anthranosides A–C, anthranilate derivatives from a sponge-derived Streptomyces sp. CMN-62. Org. Lett. 2018, 20, 5466–5469. [Google Scholar] [CrossRef]
  67. Huang, H.; Yao, Y.; He, Z.; Yang, T.; Ma, J.; Tian, X.; Li, Y.; Huang, C.; Chen, X.; Li, W.; et al. Antimalarial β-carboline and indolactam alkaloids from Marinactinospora thermotolerans, a deep sea isolate. J. Nat. Prod. 2011, 74, 2122–2127. [Google Scholar] [CrossRef]
  68. Wang, Y.; Tang, X.; Shao, Z.; Ren, J.; Liu, D.; Proksch, P.; Lin, W. Indole-based alkaloids from deep-sea bacterium Shewanella piezotolerans with antitumor activities. J. Antibiot. (Tokyo) 2014, 67, 395–399. [Google Scholar] [CrossRef]
  69. Cheng, Z.; Lou, L.; Liu, D.; Li, X.; Proksch, P.; Yin, S.; Lin, W. Versiquinazolines A–K, fumiquinazoline-type alkaloids from the gorgonian-derived fungus Aspergillus versicolor LZD-14-1. J. Nat. Prod. 2016, 79, 2941–2952. [Google Scholar] [CrossRef]
  70. Cheng, Z.; Liu, D.; Cheng, W.; Proksch, P.; Lin, W. Versiquinazolines L–Q, new polycyclic alkaloids from the marine-derived fungus Aspergillus versicolor. RSC Adv. 2018, 8, 31427–31439. [Google Scholar] [CrossRef]
  71. Zhuang, Y.; Teng, X.; Wang, Y.; Liu, P.; Li, G.; Zhu, W. New quinazolinone alkaloids within rare amino acid residue from coral-associated fungus, Aspergillus versicolor LCJ-5-4. Org. Lett. 2011, 13, 1130–1133. [Google Scholar] [CrossRef]
  72. Song, F.; Ren, B.; Yu, K.; Chen, C.; Guo, H.; Yang, N.; Gao, H.; Liu, X.; Liu, M.; Tong, Y.; et al. Quinazolin-4-one coupled with pyrrolidin-2-iminium alkaloids from marine-derived fungus Penicillium aurantiogriseum. Mar. Drugs 2012, 10, 1297–1306. [Google Scholar] [CrossRef]
  73. Yu, G.; Wang, Y.; Yu, R.; Feng, Y.; Wang, L.; Che, Q.; Gu, Q.; Li, D.; Li, J.; Zhu, T. Chetracins E and F, cytotoxic epipolythiodioxopiperazines from the marine-derived fungus: Acrostalagmus luteoalbus HDN13-530. RSC Adv. 2018, 8, 53–58. [Google Scholar] [CrossRef]
  74. Du, F.Y.; Li, X.; Li, X.M.; Zhu, L.W.; Wang, B.G. Indolediketopiperazine alkaloids from Eurotium cristatum EN-220, an endophytic fungus isolated from the marine alga Sargassum thunbergii. Mar. Drugs 2017, 15, 24. [Google Scholar] [CrossRef]
  75. Zhang, P.; Mandi, A.; Li, X.M.; Du, F.Y.; Wang, J.N.; Li, X.; Kurtan, T.; Wang, B.G. Varioxepine A, a 3H-oxepine-containing alkaloid with a new oxa-cage from the marine algal-derived endophytic fungus Paecilomyces variotii. Org. Lett. 2014, 16, 4834–4837. [Google Scholar] [CrossRef]
  76. Zhong, W.M.; Wang, J.F.; Shi, X.F.; Wei, X.Y.; Chen, Y.C.; Zeng, Q.; Xiang, Y.; Chen, X.Y.; Tian, X.P.; Xiao, Z.H.; et al. Eurotiumins A–E, five new alkaloids from the marine-derived fungus Eurotium sp. SCSIO F452. Mar. Drugs 2018, 16, 136. [Google Scholar] [CrossRef]
  77. Li, H.; Sun, W.; Deng, M.; Zhou, Q.; Wang, J.; Liu, J.; Chen, C.; Qi, C.; Luo, Z.; Xue, Y.; et al. Asperversiamides, linearly fused prenylated indole alkaloids from the marine-derived fungus Aspergillus versicolor. J. Org. Chem. 2018, 83, 8483–8492. [Google Scholar] [CrossRef]
  78. Xu, X.; Zhang, X.; Nong, X.; Wei, X.; Qi, S. Oxindole alkaloids from the fungus Penicillium commune DFFSCS026 isolated from deep-sea-derived sediments. Tetrahedron 2015, 71, 610–615. [Google Scholar] [CrossRef]
  79. Zhou, R.; Liao, X.; Li, H.; Li, J.; Feng, P.; Zhao, B.; Xu, S. Isolation and synthesis of misszrtine A: A novel indole alkaloid from marine sponge-associated Aspergillus sp. SCSIO XWS03F03. Front. Chem. 2018, 6, 212. [Google Scholar] [CrossRef]
  80. Wu, C.J.; Li, C.W.; Gao, H.; Huang, X.J.; Cui, C.B. Penicimutamides D–E: Two new prenylated indole alkaloids from a mutant of the marine-derived: Penicillium purpurogenum G59. RSC Adv. 2017, 7, 24718–24722. [Google Scholar] [CrossRef]
  81. Zhu, M.; Zhang, X.; Feng, H.; Che, Q.; Zhu, T.; Gu, Q.; Li, D. Campyridones A–D, pyridone alkaloids from a mangrove endophytic fungus Campylocarpon sp. HDN13-307. Tetrahedron 2016, 72, 5679–5683. [Google Scholar] [CrossRef]
  82. Cui, H.; Yu, J.; Chen, S.; Ding, M.; Huang, X.; Yuan, J.; She, Z. Alkaloids from the mangrove endophytic fungus Diaporthe phaseolorum SKS019. Bioorganic Med. Chem. Lett. 2017, 27, 803–807. [Google Scholar] [CrossRef]
  83. Shao, C.L.; Wang, C.Y.; Gu, Y.C.; Wei, M.Y.; Pan, J.H.; Deng, D.S.; She, Z.G.; Lin, Y.C. Penicinoline, a new pyrrolyl 4-quinolinone alkaloid with an unprecedented ring system from an endophytic fungus Penicillium sp. Bioorganic Med. Chem. Lett. 2010, 20, 3284–3286. [Google Scholar] [CrossRef]
  84. Ji, N.Y.; Liu, X.H.; Miao, F.P.; Qiao, M.F. Aspeverin, a new alkaloid from an algicolous strain of Aspergillus versicolor. Org. Lett. 2013, 15, 2327–2329. [Google Scholar] [CrossRef]
  85. Zhang, Z.; Min, X.; Huang, J.; Zhong, Y.; Wu, Y.; Li, X.; Deng, Y.; Jiang, Z.; Shao, Z.; Zhang, L.; et al. Cytoglobosins H and I, new antiproliferative cytochalasans from deep-sea-derived fungus Chaetomium globosum. Mar. Drugs 2016, 14, 233. [Google Scholar] [CrossRef]
  86. Zhu, X.; Zhou, D.; Liang, F.; Wu, Z.; She, Z.; Li, C. Penochalasin K, a new unusual chaetoglobosin from the mangrove endophytic fungus Penicillium chrysogenum V11 and its effective semi-synthesis. Fitoterapia 2017, 123, 23–28. [Google Scholar] [CrossRef]
  87. Liu, Q.Y.; Zhou, T.; Zhao, Y.Y.; Chen, L.; Gong, M.W.; Xia, Q.W.; Ying, M.G.; Zheng, Q.H.; Zhang, Q.Q. Antitumor effects and related mechanisms of penicitrinine A, a novel alkaloid with a unique spiro skeleton from the marine fungus Penicillium citrinum. Mar. Drugs 2015, 13, 4733–4753. [Google Scholar] [CrossRef]
  88. He, J.B.; Ji, Y.N.; Hu, D.B.; Zhang, S.; Yan, H.; Liu, X.C.; Luo, H.R.; Zhu, H.J. Structure and absolute configuration of penicilliumine, a new alkaloid from Penicillium commune 366606. Tetrahedron Lett. 2014, 55, 2684–2686. [Google Scholar] [CrossRef]
  89. Wu, Z.; Liu, D.; Proksch, P.; Guo, P.; Lin, W. Punctaporonins H–M: Caryophyllene-Type Sesquiterpenoids from the Sponge-Associated Fungus Hansfordia sinuosae. Mar. Drugs 2014, 3904–3916. [Google Scholar] [CrossRef]
  90. Li, D.; Xu, Y.; Shao, C.L.; Yang, R.Y.; Zheng, C.J.; Chen, Y.Y.; Fu, X.M.; Qian, P.Y.; She, Z.G.; De Voogd, N.J.; et al. Antibacterial bisabolane-type sesquiterpenoids from the sponge-derived fungus Aspergillus sp. Mar. Drugs 2012, 10, 234–241. [Google Scholar] [CrossRef]
  91. Fang, W.; Lin, X.; Zhou, X.; Wan, J.; Lu, X.; Yang, B.; Ai, W.; Lin, J.; Zhang, T.; Tu, Z.; et al. Cytotoxic and antiviral nitrobenzoyl sesquiterpenoids from the marine-derived fungus Aspergillus ochraceus Jcma1F17. MedChemComm 2014, 5, 701–705. [Google Scholar] [CrossRef]
  92. Qiu, L.; Wang, P.; Liao, G.; Zeng, Y.; Cai, C.; Kong, F.; Guo, Z.; Proksch, P.; Dai, H.; Mei, W. New eudesmane-type sesquiterpenoids from the mangrove-derived endophytic fungus Penicillium sp. J-54. Mar. Drugs 2018, 16, 108. [Google Scholar] [CrossRef]
  93. Li, H.J.; Xie, Y.L.; Xie, Z.L.; Chen, Y.; Lam, C.K.; Lan, W.J. Chondrosterins A–E, Triquinane-type sesquiterpenoids from soft coral-associated fungus Chondrostereum sp. Mar. Drug. 2012, 10, 627–638. [Google Scholar] [CrossRef]
  94. Li, Y.; Liu, D.; Cheng, Z.; Proksch, P.; Lin, W. Cytotoxic trichothecene-type sesquiterpenes from the sponge-derived fungus: Stachybotrys chartarum with tyrosine kinase inhibition. RSC Adv. 2017, 7, 7259–7267. [Google Scholar] [CrossRef]
  95. Shi, Z.Z.; Fang, S.T.; Miao, F.P.; Yin, X.L.; Ji, N.Y. Trichocarotins A–H and trichocadinin A, nine sesquiterpenes from the marine-alga-epiphytic fungus Trichoderma virens. Bioorg. Chem. 2018, 81, 319–325. [Google Scholar] [CrossRef]
  96. Fang, W.; Wang, J.; Wang, J.; Shi, L.; Li, K.; Lin, X.; Min, Y.; Yang, B.; Tang, L.; Liu, Y.; et al. Cytotoxic and antibacterial eremophilane sesquiterpenes from the marine-derived fungus Cochliobolus lunatus SCSIO41401. J. Nat. Prod. 2018, 81, 1405–1410. [Google Scholar] [CrossRef]
  97. Meng, L.H.; Li, X.M.; Liu, Y.; Wang, B.G. Penicibilaenes A and B, sesquiterpenes with a tricyclo[6.3.1.01,5]dodecane skeleton from the marine isolate of Penicillium bilaiae MA-267. Org. Lett. 2014, 16, 6052–6055. [Google Scholar] [CrossRef]
  98. Yang, X.W.; Peng, K.; Liu, Z.; Zhang, G.Y.; Li, J.; Wang, N.; Steinmetz, A.; Liu, Y. Strepsesquitriol, a rearranged zizaane-type sesquiterpenoid from the deep-sea-derived actinomycete Streptomyces sp. SCSIO 10355. J. Nat. Prod. 2013, 2360–2363. [Google Scholar] [CrossRef]
  99. Song, Y.P.; Fang, S.T.; Miao, F.P.; Yin, X.L.; Ji, N.Y. Diterpenes and sesquiterpenes from the marine algicolous fungus Trichoderma harzianum X-5. J. Nat. Prod. 2018, 81, 2553–2559. [Google Scholar] [CrossRef]
  100. Reveglia, P.; Cimmino, A.; Masi, M.; Nocera, P.; Berova, N.; Ellestad, G.; Evidente, A. Pimarane diterpenes: Natural source, stereochemical configuration, and biological activity. Chirality 2018, 1115–1134. [Google Scholar] [CrossRef]
  101. Sun, L.; Li, D.L.; Tao, M.; Chen, Y.; Dan, F.; Zhang, W. Scopararanes C–G: New oxygenated pimarane diterpenes from the marine sediment-derived fungus Eutypella Scoparia FS26. Mar. Drugs 2012, 10, 539–550. [Google Scholar] [CrossRef]
  102. Liu, H.; Zhang, L.; Chen, Y.; Li, S.; Tan, G.; Sun, Z.; Pan, Q.; Ye, W.; Li, H.; Zhang, W. Cytotoxic pimarane-type diterpenes from the marine sediment-derived fungus Eutypella sp. FS46. Nat. Prod. Res. 2017, 31, 404–410. [Google Scholar] [CrossRef]
  103. Li, X.D.; Li, X.; Li, X.M.; Xu, G.M.; Zhang, P.; Meng, L.H.; Wang, B.G. Tetranorlabdane diterpenoids from the deep sea sediment-derived fungus Aspergillus wentii SD-310. Planta Med. 2016, 82, 877–881. [Google Scholar] [CrossRef]
  104. Li, X.; Li, X.D.; Li, X.M.; Xu, G.M.; Liu, Y.; Wang, B.G. Wentinoids A–F, six new isopimarane diterpenoids from Aspergillus wentii SD-310, a deep-sea sediment derived fungus. RSC Adv. 2017, 7, 4387–4394. [Google Scholar] [CrossRef]
  105. Li, X.D.; Li, X.; Li, X.M.; Xu, G.M.; Liu, Y.; Wang, B.G. 20-nor-isopimarane epimers produced by Aspergillus wentii SD-310, a fungal strain obtained from deep sea sediment. Mar. Drugs 2018, 16, 440. [Google Scholar] [CrossRef]
  106. Huang, X.; Huang, H.; Li, H.; Sun, X.; Huang, H.; Lu, Y.; Lin, Y.; Long, Y.; She, Z. Asperterpenoid A, a new sesterterpenoid as an inhibitor of Mycobacterium tuberculosis protein tyrosine phosphatase B from the culture of Aspergillus sp. 16-5c. Org. Lett. 2013, 15, 721–723. [Google Scholar] [CrossRef]
  107. Xiao, Z.; Huang, H.; Shao, C.; Xia, X.; Ma, L.; Huang, X.; Lu, Y.; Lin, Y.; Long, Y.; She, Z. Asperterpenols A and B, new sesterterpenoids isolated from a mangrove endophytic fungus Aspergillus sp. 085242. Org. Lett. 2013, 15, 2522–2525. [Google Scholar] [CrossRef]
  108. Guo, C.J.; Knox, B.P.; Chiang, Y.M.; Lo, H.C.; Sanchez, J.F.; Lee, K.H.; Oakley, B.R.; Bruno, K.S.; Wang, C.C.C. Molecular genetic characterization of a cluster in A. terreus for biosynthesis of the meroterpenoid terretonin. Org. Lett. 2012, 14, 5684–5687. [Google Scholar] [CrossRef]
  109. Shi, Z.; Miao, F.; Fang, S.; Liu, X.; Yin, X.; Ji, N. Sesteralterin and tricycloalterfurenes A–D: terpenes with rarely occurring frameworks from the marine-alga-epiphytic fungus Alternaria alternata k21-1. J. Nat. Prod. 2017, 80, 2524–2529. [Google Scholar] [CrossRef]
  110. Zhang, J.; Yuan, B.; Liu, D.; Gao, S.; Proksch, P. Brasilianoids A–F, New meroterpenoids from the sponge-associated fungus Penicillium brasilianum. Front. Chem. 2018, 6, 314. [Google Scholar] [CrossRef]
  111. Chen, S.; Ding, M.; Liu, W.; Huang, X.; Liu, Z.; Lu, Y.; Liu, H.; She, Z. Anti-inflammatory meroterpenoids from the mangrove endophytic fungus Talaromyces amestolkiae YX1. Phytochemistry 2018, 146, 8–15. [Google Scholar] [CrossRef]
  112. Peng, J.; Zhang, X.; Wang, W.; Zhu, T.; Gu, Q.; Li, D. Austalides S–U, new meroterpenoids from the sponge-derived fungus Aspergillus aureolatus HDN14-107. Mar. Drugs 2016, 14, 131. [Google Scholar] [CrossRef]
  113. Zhang, P.; Li, Y.; Jia, C.; Lang, J.; Niaz, S.I.; Li, J.; Yuan, J.; Yu, J.; Chen, S.; Liu, L. Antiviral and anti-inflammatory meroterpenoids: Stachybonoids A–F from the crinoid-derived fungus Stachybotrys chartarum 952. RSC Adv. 2017, 7, 49910–49916. [Google Scholar] [CrossRef]
  114. Liu, N.; Shang, F.; Xi, L.J.; Huang, Y. Tetroazolemycins A and B, two new oxazole-thiazole siderophores from deep-sea Streptomyces olivaceus FXJ8.012. Mar. Drugs 2013, 11, 1524–1533. [Google Scholar] [CrossRef]
  115. Chen, Y.; Chen, R.; Xu, J.; Tian, Y.; Xu, J.; Liu, Y. Two new altenusin/thiazole hybrids and a new benzothiazole derivative from the marine sponge-derived fungus Alternaria sp. SCSIOS02F49. Molecules 2018, 23, 2844. [Google Scholar] [CrossRef]
  116. Chen, H.; Huang, M.; Li, X.; Liu, L.; Chen, B.; Wang, J.; Lin, Y. Phochrodines A–D, first naturally occurring new chromenopyridines from mangrove entophytic fungus Phomopsis sp. 33#. Fitoterapia 2018, 124, 103–107. [Google Scholar]
  117. Sun, Y.; Liu, J.; Li, L.; Gong, C.; Wang, S.; Yang, F.; Hua, H.; Lin, H. New butenolide derivatives from the marine sponge-derived fungus Aspergillus terreus. Bioorganic Med. Chem. Lett. 2018, 28, 315–318. [Google Scholar] [CrossRef]
  118. Ding, L.; Li, T.; Liao, X.; He, S.; Xu, S. Asperitaconic acids A–C, antibacterial itaconic acid derivatives produced by a marine-derived fungus of the genus Aspergillus. J. Antibiot. (Tokyo) 2018, 71, 902–904. [Google Scholar] [CrossRef]
  119. Zhang, S.; Gui, C.; Shao, M.; Kumar, P.S.; Huang, H.; Ju, J. Antimicrobial tunicamycin derivatives from the deep sea-derived Streptomyces xinghaiensis SCSIO S15077. Nat. Prod. Res. 2018. [Google Scholar] [CrossRef]
  120. Huang, D.; Shao, Z.Z.; Yu, Y.; Cai, M.M.; Zheng, L.Y.; Li, G.Y.; Yu, Z.N.; Yi, X.F.; Zhang, J.B.; Hao, F.H. Identification, characteristics and mechanism of 1-deoxy-N-acetylglucosamine from deep-sea Virgibacillus dokdonensis MCCC 1A00493. Mar. Drugs 2018, 16, 52. [Google Scholar] [CrossRef]
  121. Chen, M.; Wang, K.; Liu, M.; She, Z.; Wang, C. Bioactive Steroid Derivatives and Butyrolactone Derivatives from a Gorgonian-Derived Aspergillus sp. Fungus. 2015, 12, 1398–1406. [Google Scholar]
  122. Chen, L.; Zhang, Q.Y.; Jia, M.; Ming, Q.L.; Yue, W.; Rahman, K.; Qin, L.P.; Han, T. Endophytic fungi with antitumor activities: Their occurrence and anticancer compounds. Crit. Rev. Microbiol. 2016, 42, 454–473. [Google Scholar] [CrossRef]
  123. Ancheeva, E.; Daletos, G.; Proksch, P. Lead compounds from mangrove-associated microorganisms. Mar. Drugs 2018, 16, 319. [Google Scholar] [CrossRef]
Figure 1. Selected polyketides 130 isolated from marine-derived microbes.
Figure 1. Selected polyketides 130 isolated from marine-derived microbes.
Marinedrugs 17 00339 g001
Figure 2. Polyketides 3173, isolated from marine microbes.
Figure 2. Polyketides 3173, isolated from marine microbes.
Marinedrugs 17 00339 g002
Figure 3. Polyketides 74115 isolated from marine microbes.
Figure 3. Polyketides 74115 isolated from marine microbes.
Marinedrugs 17 00339 g003
Figure 4. Peptides 116143 from marine microbes.
Figure 4. Peptides 116143 from marine microbes.
Marinedrugs 17 00339 g004
Figure 5. Alkaloids 144-199 from marine microbes.
Figure 5. Alkaloids 144-199 from marine microbes.
Marinedrugs 17 00339 g005
Figure 6. Alkaloids 200239 isolated from marine-derived microbes.
Figure 6. Alkaloids 200239 isolated from marine-derived microbes.
Marinedrugs 17 00339 g006
Figure 7. Terpenoids 240294 from marine-derived microbes.
Figure 7. Terpenoids 240294 from marine-derived microbes.
Marinedrugs 17 00339 g007
Figure 8. Terpenoids 295331 from marine-derived microbes.
Figure 8. Terpenoids 295331 from marine-derived microbes.
Marinedrugs 17 00339 g008
Figure 9. Mixed biosynthesis and miscellaneous compounds 332349.
Figure 9. Mixed biosynthesis and miscellaneous compounds 332349.
Marinedrugs 17 00339 g009
Figure 10. Analysis of publications analyzed in this review. (a) Number of publications each year, split my organism type; (b) percentage breakdown of publications by organism type; (c) publications by journal; (d) percentage of publications by sample collection location; (e) number of publications for each biological activity; and, (f) percentage of publications by structure class of new/active compounds.
Figure 10. Analysis of publications analyzed in this review. (a) Number of publications each year, split my organism type; (b) percentage breakdown of publications by organism type; (c) publications by journal; (d) percentage of publications by sample collection location; (e) number of publications for each biological activity; and, (f) percentage of publications by structure class of new/active compounds.
Marinedrugs 17 00339 g010

Share and Cite

MDPI and ACS Style

Sun, W.; Wu, W.; Liu, X.; Zaleta-Pinet, D.A.; Clark, B.R. Bioactive Compounds Isolated from Marine-Derived Microbes in China: 2009–2018. Mar. Drugs 2019, 17, 339. https://doi.org/10.3390/md17060339

AMA Style

Sun W, Wu W, Liu X, Zaleta-Pinet DA, Clark BR. Bioactive Compounds Isolated from Marine-Derived Microbes in China: 2009–2018. Marine Drugs. 2019; 17(6):339. https://doi.org/10.3390/md17060339

Chicago/Turabian Style

Sun, Weiwei, Wenhui Wu, Xueling Liu, Diana A. Zaleta-Pinet, and Benjamin R. Clark. 2019. "Bioactive Compounds Isolated from Marine-Derived Microbes in China: 2009–2018" Marine Drugs 17, no. 6: 339. https://doi.org/10.3390/md17060339

APA Style

Sun, W., Wu, W., Liu, X., Zaleta-Pinet, D. A., & Clark, B. R. (2019). Bioactive Compounds Isolated from Marine-Derived Microbes in China: 2009–2018. Marine Drugs, 17(6), 339. https://doi.org/10.3390/md17060339

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop